RGC-32 As a Potential Biomarker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis
Journal of the Neurological Sciences（2015）
Key words
RGC-32,Multiple sclerosis,Glatiramer acetate,Biomarker,FasL,IL-21
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined